OBJECTIVE: Chronic pain is a common neurological comorbidity of human immunodeficiency virus (HIV)-1 infection, but the etiological cause remains elusive. The objective of this study was to identify the HIV-1 causal factor that critically contributes to the pathogenesis of HIV-associated pain. METHODS: We first compared the levels of HIV-1 proteins in postmortem tissues of the spinal cord dorsal horn (SDH) from HIV-1/acquired immunodeficiency syndrome patients who developed chronic pain (pain-positive HIV-1 patients) and HIV-1 patients who did not develop chronic pain (pain-negative HIV-1 patients). Then we used the HIV-1 protein that was specifically increased in the pain-positive patients to generate mouse models. Finally, we performed comparative analyses on the pathological changes in the models and the HIV-1 patients. RESULTS: We found that HIV-1 gp120 was significantly higher in pain-positive HIV-1 patients (vs pain-negative HIV-1 patients). This finding suggested that gp120 was a potential causal factor of the HIV-associated pain. To test this hypothesis, we used a mouse model generated by intrathecal injection of gp120 and compared the pathologies of the model and the pain-positive human HIV-1 patients. The results showed that the mouse model and pain-positive human HIV-1 patients developed extensive similarities in their pathological phenotypes, including pain behaviors, peripheral neuropathy, glial reactivation, synapse degeneration, and aberrant activation of pain-related signaling pathways in the SDH. INTERPRETATION: Our findings suggest that gp120 may critically contribute to the pathogenesis of HIV-associated pain.
OBJECTIVE:Chronic pain is a common neurological comorbidity of human immunodeficiency virus (HIV)-1 infection, but the etiological cause remains elusive. The objective of this study was to identify the HIV-1 causal factor that critically contributes to the pathogenesis of HIV-associated pain. METHODS: We first compared the levels of HIV-1 proteins in postmortem tissues of the spinal cord dorsal horn (SDH) from HIV-1/acquired immunodeficiency syndromepatients who developed chronic pain (pain-positive HIV-1patients) and HIV-1patients who did not develop chronic pain (pain-negative HIV-1patients). Then we used the HIV-1 protein that was specifically increased in the pain-positive patients to generate mouse models. Finally, we performed comparative analyses on the pathological changes in the models and the HIV-1patients. RESULTS: We found that HIV-1gp120 was significantly higher in pain-positive HIV-1patients (vs pain-negative HIV-1patients). This finding suggested that gp120 was a potential causal factor of the HIV-associated pain. To test this hypothesis, we used a mouse model generated by intrathecal injection of gp120 and compared the pathologies of the model and the pain-positive humanHIV-1patients. The results showed that the mouse model and pain-positive humanHIV-1patients developed extensive similarities in their pathological phenotypes, including pain behaviors, peripheral neuropathy, glial reactivation, synapse degeneration, and aberrant activation of pain-related signaling pathways in the SDH. INTERPRETATION: Our findings suggest that gp120 may critically contribute to the pathogenesis of HIV-associated pain.
Authors: E D Milligan; K A O'Connor; K T Nguyen; C B Armstrong; C Twining; R P Gaykema; A Holguin; D Martin; S F Maier; L R Watkins Journal: J Neurosci Date: 2001-04-15 Impact factor: 6.167
Authors: I P Everall; R K Heaton; T D Marcotte; R J Ellis; J A McCutchan; J H Atkinson; I Grant; M Mallory; E Masliah Journal: Brain Pathol Date: 1999-04 Impact factor: 6.508
Authors: Peter R Kamerman; Philippa J Moss; Juliane Weber; Victoria C J Wallace; Andrew S C Rice; Wenlong Huang Journal: J Peripher Nerv Syst Date: 2012-03 Impact factor: 3.494
Authors: Scott R Evans; Ronald J Ellis; Huichao Chen; Tzu-min Yeh; Anthony J Lee; Giovanni Schifitto; Kunling Wu; Ronald J Bosch; Justin C McArthur; David M Simpson; David B Clifford Journal: AIDS Date: 2011-04-24 Impact factor: 4.177
Authors: Lisa M Mangus; Rachel L Weinberg; Audrey C Knight; Suzanne E Queen; Robert J Adams; Joseph L Mankowski Journal: J Neuropathol Exp Neurol Date: 2019-01-01 Impact factor: 3.685
Authors: Michael A Owens; Romy Parker; Rachael L Rainey; Cesar E Gonzalez; Dyan M White; Anooshah E Ata; Jennifer I Okunbor; Sonya L Heath; Jessica S Merlin; Burel R Goodin Journal: J Neurovirol Date: 2018-11-09 Impact factor: 2.643